Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
作者信息
SCHEINBERG I H, MORELL A G
出版信息
J Clin Invest. 1957 Aug;36(8):1193-201. doi: 10.1172/JCI103515.
Abstract
摘要
相似文献
1
Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
J Clin Invest. 1957 Aug;36(8):1193-201. doi: 10.1172/JCI103515.
2
Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
Prog Neurobiol (1956). 1956;1:52-63.
3
Observations on ceruloplasmin in Wilson's disease.
J Clin Invest. 1959 Oct;38(10 Pt 1-2):1672-82. doi: 10.1172/JCI103945.
4
[Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
Rinsho Byori. 1974 Oct;22(10 Suppl):191.
5
[Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
Klin Wochenschr. 1956 Sep 15;34(35-36):961-8. doi: 10.1007/BF01473248.
6
[Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
Neurol Neurochir Pol. 1971 Sep-Oct;5(5):622-9.
7
Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
Science. 1952 Oct 31;116(3018):484-5. doi: 10.1126/science.116.3018.484.
8
Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
Am J Med. 1960 Apr;28:555-63. doi: 10.1016/0002-9343(60)90150-9.
9
[The onset of psychiatric disorders and Wilson's disease].
Encephale. 2007 Dec;33(6):924-32. doi: 10.1016/j.encep.2006.08.009. Epub 2007 Sep 5.
10
Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
J Clin Invest. 1955 Oct;34(10):1498-508. doi: 10.1172/JCI103201.
引用本文的文献
1
A family study of the biochemical defects in Wilson's disease.
J Clin Pathol. 1961 May;14(3):264-70. doi: 10.1136/jcp.14.3.264.
2
THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER.
J Clin Invest. 1961 Oct;40(10):1834-40. doi: 10.1172/JCI104407.
3
DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE.
J Clin Invest. 1961 Apr;40(4):707-15. doi: 10.1172/JCI104304.
4
Hepatocellular changes in Wilson's disease. Histochemical and electron microscopic studies.
Am J Pathol. 1962 Sep;41(3):315-28.
5
Observations on ceruloplasmin in Wilson's disease.
J Clin Invest. 1959 Oct;38(10 Pt 1-2):1672-82. doi: 10.1172/JCI103945.
6
OBSERVATIONS ON THE MECHANISM OF ABSORPTION OF COPPER BY THE SMALL INTESTINE.
J Physiol. 1965 May;178(1):111-26. doi: 10.1113/jphysiol.1965.sp007618.
7
OBSERVATIONS ON THE NATURE OF THE UNDERLYING DISORDER AND THE OCCURRENCE OF ASSOCIATED PLASMA TRANSPORT ABNORMALITIES IN A PATIENT WITH AN IDIOPATHIC INCREASE IN THE PLASMA THYROXINE-BINDING GLOBULIN.
J Clin Invest. 1964 Dec;43(12):2266-71. doi: 10.1172/JCI105100.
8
ABSORPTION OF COPPER IN MALABSORPTION SYNDROMES.
J Clin Invest. 1964 Jun;43(6):1049-55. doi: 10.1172/JCI104988.
9
The effects of some ions and chelating agents on the oxidase activity of caeruloplasmin.
Biochem J. 1960 Oct;77(1):66-73. doi: 10.1042/bj0770066.
10
The treatment of hepatolenticular degeneration.
Proc R Soc Med. 1959 Jan;52(1):62-4. doi: 10.1177/003591575905200112.
本文引用的文献
1
Experimental Copper Poisoning.
Am J Pathol. 1931 Jul;7(4):351-364.3.
2
The Relation of Chronic Poisoning with Copper to Hemochromatosis.
Am J Pathol. 1925 Jan;1(1):117-33.
3
Micro-determination of copper in biological material.
Biochem J. 1940 Sep;34(8-9):1202-8. doi: 10.1042/bj0341202.
4
Oxidase reactions in human plasma caused by coeruloplasmin.
Scand J Clin Lab Invest. 1951;3(2):103-7. doi: 10.3109/00365515109060581.
5
The copper of ascorbic acid oxidase; exchange studies with radioactive copper.
J Biol Chem. 1951 Jul;191(1):11-20.
6
The copper of ascorbic acid oxidase; experiments with an ion exchange resin.
J Biol Chem. 1951 Jul;191(1):1-10.
7
Metabolic studies in Wilson's disease using Cu64.
J Lab Clin Med. 1955 Apr;45(4):623-31.
8
[Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
Klin Wochenschr. 1956 Sep 15;34(35-36):961-8. doi: 10.1007/BF01473248.
9
Penicillamine, a new oral therapy for Wilson's disease.
Am J Med. 1956 Oct;21(4):487-95. doi: 10.1016/0002-9343(56)90066-3.
10
Metalloenzymes and myocardial infarction. I. The relation between serum copper and ceruloplasmin and its catalytic activity.
N Engl J Med. 1956 Jul 19;255(3):105-9. doi: 10.1056/NEJM195607192550301.
Zotero 插件